GENZ-112638, an oral ceramide analog for substrate inhibition therapy of Gaucher disease

被引：0
|
作者：
Cheng, S. H.
McEachern, K. M.
Siegel, C.
Fung, J.
Komarnitsky, S.
Chuang, W-L
Johnson, J.
Hutto, E.
Grabowski, G. A.
Zhang, K.
Marshall, J.
Sung, C.
Peterschmitt, M. J.
Copeland, D. P.
机构：
[1] Genzyme Corp, Framingham, MA 01701 USA
[2] Cincinnati Childrens Hosp Res Fdn, Cincinnati, OH USA
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 2006年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [1] A phase 2 study of eliglustat tartrate (Genz-112638), an oral substrate reduction therapy for Gaucher disease type 1
    Lukina, Elena
    Watman, Nora
    Arreguin, Elsa Avila
    Banikazemi, Maryam
    Dragosky, Marta
    Iastrebner, Marcelo
    Rosenbaum, Hanna
    Phillips, Mici
    Pastores, Gregory M.
    Rosenthal, Daniel I.
    Kaper, Mathilde
    Singh, Tejdip
    Puga, Ana Cristina
    Bonate, Peter L.
    Peterschmitt, M. Judith
    BLOOD, 2010, 116 (06) : 893 - 899
  • [2] Genz-112638: A novel orally available ceramide-based inhibitor of glucosylceramide synthase for treating Gaucher disease
    McEachern, Kerry
    Siegel, C.
    Fung, J.
    Chuang, W. L.
    Hutto, E.
    Sung, C.
    Blankstein, L.
    Peterschmitt, M. J.
    Grabowski, G. A.
    Copeland, D. P.
    Cheng, S. H.
    Marshall, J.
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S17 - S17
  • [3] Bone response to Genz-112638 in a Phase 2 study in Gaucher disease type 1
    Peterschmitt, M.
    Lukina, Elena
    Watman, Nora
    Avila Arreguin, Elsa
    Pastores, Gregory
    Iastrebner, Marcelo
    Dragosky, Marta
    Rosenbaum, Hanna
    Phillips, Mici
    Kaper, Mathilde
    Singh, Tejdip
    Puga, Ana Cristina
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S30 - S30
  • [4] GENZ-112638, AN INVESTIGATIONAL ORAL THERAPY FOR GAUCHER DISEASE TYPE 1: PHASE 2 CLINICAL TRIAL RESULTS AFTER ONE YEAR OF TREATMENT
    Lukina, E.
    Watman, N.
    Arreguin, E.
    Banikazemi, M.
    Pastores, G.
    Iastrebner, M.
    Dragosky, M.
    Rosenbaum, H.
    Zimran, A.
    Kaper, M.
    Smith, S. E.
    Puga, A. C.
    Peterschmitt, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 41 - 41
  • [5] PRELIMINARY RESULTS OF A PHASE II CLINICAL TRIAL OF GENZ-112638 IN PATIENTS WITH TYPE 1 GAUCHER DISEASE
    Puga, A. Cristina
    Lukina, E.
    Watman, N.
    Banikazemi, M.
    Iastrebner, M.
    Rosenbaum, H.
    Zimran, A.
    Arreguin, E. Avila
    O'Brien, F.
    Smith, S. E.
    Peterschmitt, J.
    CLINICAL THERAPEUTICS, 2008, 30 : S103 - S104
  • [6] Genz-112638, an investigational oral treatment for Gaucher disease type 1: Preliminary Phase 2 clinical trial results
    Peterschmitt, Judith
    Lukina, Elena
    Watman, Nora
    Arreguin, Elsa
    Banikazemi, Maryam
    Pastores, Gregory
    Lastrebner, Marcelo
    Dragosky, Marta
    Rosenbaum, Hanna
    Zimran, Ari
    O'Brien, Fanny
    Smith, Sharon
    Puga, Ana Cristina
    MOLECULAR GENETICS AND METABOLISM, 2009, 96 (02) : S34 - S34
  • [7] Preliminary results of a phase II clinical trial of Genz-112638 in patients with type I Gaucher disease
    Peterschmitt, Judith
    Lukina, Elena
    Watman, Nora
    Banikazemi, Maryam
    Iastrebner, Marcelo
    Rosenbaum, Hanna
    Zimran, Ari
    Arreguin, Elsa Avila
    O'Brien, Fanny
    Smith, Sharon
    Puga, Ana Cristina
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S32 - S33
  • [8] Preliminary results of a phase 2 clinical trial of Genz-112638 in patients with type I Gaucher disease
    Lukina, E.
    Watman, N.
    Arreguin, E. A.
    Banikazemi, M.
    Iastrebner, M.
    Rosenbaum, H.
    Zimran, A.
    O'Brien, F.
    Smith, S. E.
    Puga, A. C.
    Peterschmitt, J.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 114 - 114
  • [9] IMPROVEMENT OF BONE MANIFESTATIONS OF GAUCHER DISEASE TYPE I WITH GENZ-112638: PHASE 2 TRIAL RESULTS AT 1 YEAR
    Peterschmitt, J.
    Lukina, E.
    Watman, N.
    Arreguin, E. Avila
    Banikazemi, M.
    Pastores, G.
    Iasterbner, M.
    Rosenbaum, H.
    Phillips, M.
    Kaper, M.
    Smith, S. E.
    Puga, A. C.
    MOLECULAR GENETICS AND METABOLISM, 2009, 98 (1-2) : 80 - 80
  • [10] Latest Data on Genz-112638, an Investigational Oral Therapy for Type 1 Gaucher Disease: Phase II Clinical Trial Results After 1 Year of Treatment
    Lukina, Elena
    CLINICAL THERAPEUTICS, 2009, 31 : S194 - S195
12345